BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 15621465)

  • 1. Rapid pleurodesis in symptomatic malignant pleural effusion.
    Yildirim E; Dural K; Yazkan R; Zengin N; Yildirim D; Gunal N; Sakinci U
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):19-22. PubMed ID: 15621465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
    Crnjac A; Sok M; Kamenik M
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
    Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
    Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
    Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
    Stefani A; Natali P; Casali C; Morandi U
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative treatment of malignant pleural effusions by video-assisted thoracoscopic surgery.
    Benkó I; Molnár TF; Horváth OP
    Acta Chir Hung; 1999; 38(2):131-3. PubMed ID: 10596313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
    Chella A; Ribechini A; Dini P; Adamo C; Mussi A; Angeletti CA
    Minerva Chir; 1994 Nov; 49(11):1077-82. PubMed ID: 7708227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
    Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
    Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube.
    Caglayan B; Torun E; Turan D; Fidan A; Gemici C; Sarac G; Salepci B; Kiral N
    Ann Surg Oncol; 2008 Sep; 15(9):2594-9. PubMed ID: 18594928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.
    Goodman A; Davies CW
    Lung Cancer; 2006 Oct; 54(1):51-5. PubMed ID: 16920219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of a new small-bore percutaneous pleural catheter used for treatment of malignant pleural effusions in ECOG PS 3-4 patients.
    Filosso PL; Sandri A; Felletti G; Ruffini E; Lausi PO; Oliaro A
    Eur J Surg Oncol; 2011 Dec; 37(12):1093-8. PubMed ID: 21963043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
    Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
    Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
    J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pleural effusion treatment outcomes: pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomy.
    Luh SP; Chen CY; Tzao CY
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):332-6. PubMed ID: 16902882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A propensity-matched comparison of pleurodesis or tunneled pleural catheter in patients undergoing diagnostic thoracoscopy for malignancy.
    Freeman RK; Ascioti AJ; Mahidhara RS
    Ann Thorac Surg; 2013 Jul; 96(1):259-63: discussion 263-4. PubMed ID: 23673067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
    Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
    Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of malignant pleural effusion by pleurodesis with talc].
    Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G
    Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
    Walter M; Türler A; Schmitz-Rixen T
    Zentralbl Chir; 1996; 121(3):216-22. PubMed ID: 8867348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy.
    Seaton KG; Patz EF; Goodman PC
    AJR Am J Roentgenol; 1995 Mar; 164(3):589-91. PubMed ID: 7532350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of malignant pleural effusion secondary to breast cancer: talc pleurodesis and pleuroperitoneal shunting.
    Saute M
    Isr J Med Sci; 1995; 31(2-3):160-2. PubMed ID: 7744586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.